Biodexa Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Biodexa Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 45% to $381,000. The net income raised on -$7,079,000 and profit margin reached -1858%. Total operating expenses were $4,328,000.
Profit Margin
| 2014 | 157K | -8.82M | -5619.11% |
|---|---|---|---|
| 2015 | 1.37M | -10.09M | -734.47% |
| 2016 | 1.32M | -6.16M | -465.68% |
| 2017 | 989K | -11.70M | -1183.52% |
| 2018 | 1.93M | -10.36M | -534.98% |
| 2019 | 674K | -9.13M | -1355.79% |
| 2020 | 343K | -22.18M | -6469.1% |
| 2021 | 578K | -5.46M | -944.64% |
| 2022 | 699K | -7.65M | -1095.28% |
| 2023 | 381K | -7.07M | -1858.01% |
BDRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 381K | 699K | 578K | 343K | 674K | 1.93M | 989K | 1.32M | 1.37M | 157K |
Cost of revenue | 4.06M | 5.11M | 4.65M | 6.06M | 7.84M | 9.35M | 8.32M | 7.73M | 70K | 0 |
Gross profit | -3.68M | -4.41M | -4.07M | -5.72M | -7.16M | -7.42M | -7.34M | -6.40M | 1.30M | 157K |
Operating exp. | ||||||||||
Research and development | 4.06M | 5.11M | 4.65M | 16.14M | 7.84M | 9.35M | 9.82M | 7.73M | 8.71M | 5.43M |
Selling and marketing | 0 | 0 | 0 | 6K | 323K | 0 | 170K | 0 | 605K | 0 |
Total operating expenses | 4.32M | 4.05M | 1.98M | 17.71M | 3.66M | 4.39M | 5.53M | 2.07M | 12.58M | 9.84M |
Operating income | -8.01M | -8.93M | -6.99M | -10.67M | -11.31M | -11.81M | -11.77M | -9.65M | -10.09M | -7.71M |
Other income (expenses), net | 529K | 444K | 892K | -430K | 395K | -585K | -1.19M | 1.26M | 1.68M | -153K |
Income before tax | -7.48M | -8.48M | -6.10M | -23.47M | -10.92M | -12.4M | -12.97M | -8.38M | -11.23M | -9.84M |
Income tax expense | -406K | 832K | 646K | 1.28M | 1.78M | 2.03M | 1.26M | 2.22M | 1.13M | 1.01M |
Net income | -7.07M | -7.65M | -5.46M | -22.18M | -9.13M | -10.36M | -11.70M | -6.16M | -10.09M | -8.82M |
Earnings per share | ||||||||||
Basic EPS | -224.13 | -619.72 | -542.31 | -4.14K | -3.98K | 0 | 0 | 0 | 0 | 0 |
Diluted EPS | -224.13 | -619.72 | -542.31 | -4.14K | -3.98K | 0 | 0 | 0 | 0 | 0 |